Our findings indicate that RAGE promotes diabetes‐induced neuroinflammation and cognitive impairment via direct binding of AAs 362–367 to RIPK1 in microglia and subsequent activation of a microglial inflammation‐related signaling pathway. Here, AGER is linked to diabetes mellitus.